Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan

Lina Madaniyazi; Xerxes Seposo; Chris Fook Sheng Ng; Aurelio Tobias; Michiko Toizumi; Hiroyuki Moriuchi; Lay-Myint Yoshida; Masahiro Hashizume

doi:10.7883/yoken.JJID.2021.312

Short Communications

Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan

Lina Madaniyazi, Xerxes Seposo, Chris Fook Sheng Ng, Aurelio Tobias, Michiko Toizumi, Hiroyuki Moriuchi, Lay-Myint Yoshida, Masahiro Hashizume

著者情報

Lina Madaniyazi
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
Xerxes Seposo
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Chris Fook Sheng Ng
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Japan
Aurelio Tobias
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Institute of Environmental Assessment and Water Research (IDAEA), Spanish Council for Scientific Research (CSIC), Spain
Michiko Toizumi
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
Hiroyuki Moriuchi
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Department of Pediatrics, Graduate School of Biomedical Sciences, Nagasaki University, Japan
Lay-Myint Yoshida
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
Masahiro Hashizume
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Japan

キーワード: respiratory syncytial virus, nonpharmaceutical interventions, COVID-19

ジャーナルフリー

2022 年 75 巻 2 号 p. 209-211

DOI https://doi.org/10.7883/yoken.JJID.2021.312

Browse “Advance online publication” version

詳細

抄録

Nonpharmaceutical interventions (NPIs) for COVID-19 can affect the current and future dynamics of respiratory syncytial virus infections (RSV). In Tokyo, RSV activity declined by 97.9% (95% CI: 94.8%–99.2%) during NPIs. A long period of NPIs could increase susceptible populations, thus enhancing the potential for large RSV outbreaks after the end of NPIs.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）